Skip to main content
. 2017 Jul 15;8(7):381–389. doi: 10.4239/wjd.v8.i7.381

Table 10.

Insulin dose (U/d) before and after autologous bone marrow derived stem cell therapy in Group IV

Patient Baseline 3 mo 6 mo
1 30 30 32
2 37 25 23
3 46 40 34
4 68 55 57
5 41 26 20
6 45 41 39
7 40 49 24
Mean ± SE 44 ± 5 38 ± 4 33 ± 5
P value 0.999 0.021